Browse Related Topics For:

Amgen

246
Biosimilars
211
BPCIA
149
Pharmaceutical Patents
148
FDA
142
Patent Infringement
127
Patent Litigation
127
Patents
126
Sandoz v Amgen
118
Sandoz
115
Pharmaceutical Industry
106
Patent Dance
70
Apotex
70
Commercial Marketing
61
SCOTUS
56
Biologics
56
Notice Requirements
54
Preliminary Injunctions
52
FDA Approval
38
aBLA
37
Popular
33
Hospira
29
Appeals
27
Declaratory Judgments
23
Generic Drugs
21
Class Action
20
Prescription Drugs
19
AbbVie
17
Amgen Inc. v Connecticut Retirement Plans
17
Class Certification
17
Petition for Writ of Certiorari
15
ERISA
14
Securities Fraud
13
Biologics Price Competition and Innovation Act of 2009
13
Fraud-on-the-Market
13
Inter Partes Review (IPR) Proceeding
12
Fiduciary Duty
12
Motion to Dismiss
12
Stock Drop Litigation
11
Certiorari
11
Dismissals
11
FIfth Third Bancorp v Dudenhoeffer
10
Genentech
9
IP License
8
ANDA
8
Pleading Standards
8
State Law Claims
7
Declaratory Relief
7
Employee Benefits
7
Healthcare
7
Injunctive Relief
7
Life Sciences
7
Patent Applications
7
Patent Invalidity
7
Pfizer
7
Securities Litigation
7
Solicitor General
7
Unfair Competition
6
EU
6
Hatch-Waxman
6
Janssen Pharmaceuticals
6
Mylan Pharmaceuticals
6
Patent Trial and Appeal Board
6
Preemption
6
Rebuttable Presumptions
5
Affordable Care Act
5
Allergan Inc
5
Biotechnology
5
Corporate Counsel
5
Disclosure Requirements
5
Discovery
5
Duty of Prudence
5
Injunctions
5
Obviousness
5
Public Health Service Act
5
Subject Matter Jurisdiction
4
Actavis Inc.
4
All Writs Act
4
AstraZeneca
4
Breach of Duty
4
Citizen Petitions
4
Counterclaims
4
European Medicines Agency (EMA)
4
Halliburton
4
Oral Argument
4
Patent-Eligible Subject Matter
4
Remedies
4
Retirement Plan
3
401k
3
Advisory Committee
3
Canada
3
Claim Construction
3
Conversion
3
Damages
3
Declaratory Rulings
3
Disclosure
3
Dispute Resolution
3
Eli Lilly
3
En Banc Review
3
ESOP
3
Exclusive Remedy
3
Failure To State A Claim
3
Information Sharing
3
Jurisdiction
3
License Applications
3
Licensing Rules
3
Marketing Authorization Application
3
Merck
3
Mootness
3
Motion for Summary Judgment
3
Permanent Injunctions
3
Petition For Rehearing
3
Samsung
3
SEC
3
Securities
3
Summary Judgment
3
Teva Pharmaceuticals
2
American Express v Italian Colors Restaurant
2
Amgen v Sandoz
2
Amicus Briefs
2
Arbitration
2
Basic v Levinson
2
CAFA
2
CAFC
2
Celltrion
2
Class Action Arbitration Waivers
2
Clinical Trials
2
Drug Approvals
2
Enablement Inquiries
2
Exclusivity
2
Federal Rules of Civil Procedure
2
First Impression
2
Fraud
2
FRCP 26
2
Gabelli v SEC
2
GlaxoSmithKline
2
Halliburton v Erica P. John Fund
2
Inside Information
2
Johnson & Johnson
2
Loss Causation
2
Material Misstatements
2
Medicaid
2
Medicare
2
Motion for Judgment
2
On-Sale Bar
2
Orange Book
2
Oxford Health v Sutter
2
Patent Exhaustion
2
Patented Medicines
2
Pre-Market Notification
2
Private Right of Action
2
Public Meetings
2
Regeneron
2
Research and Development
2
Reverse Payment Settlement Agreements
2
Safe Harbors
2
Sanofi
2
Sanofi-Aventis
2
Securities Exchange Act
2
Standard Fire Ins. Co. v. Knowles
2
Stark Law
2
Statute of Limitations
2
Stipulations
2
UK
2
USPTO
2
Vacated
2
Wal-Mart
1
Accounting
1
Administrative Procedure Act
1
Affirmative Action
1
Affirmative Defenses
1
Alien Tort Statute
1
Allergan v Sandoz
1
Already LLC
1
Amended Regulation
1
America Invents Act
1
American Express
1
Amgen v Apotex
1
Amgen v Harris
1
Amgen v Hospira
1
AMP v Myriad
1
Anti-Kickback Statute
1
Article III
1
Assignments
1
Attorney-Client Privilege
1
Bayer
1
Biogen Idec
1
biologic
1
Boehringer
1
Books & Records
1
Bowman v Monsanto
1
BPCI
1
Breach of Contract
1
Bristol-Myers Squibb
1
Business Torts
1
Calculation of Damages
1
Cancer
1
Canning v NLRB
1
Certifications
1
CETA
1
CFTC
1
CGMP
1
Chadbourne & Parke LLP v Troice
1
Citizen Suits
1
Civil Conspiracy
1
Civil Monetary Penalty
1
Clinical Laboratory Testing
1
CMS
1
Coherus
1
Collateral Order Doctrine
1
Comcast
1
Comcast v. Behrend
1
Comment Period
1
Community Trademark
1
Conflict Mineral Rules
1
Content Marketing
1
Contract Interpretation
1
Copyright
1
Corporate Governance
1
Covenant of Good Faith and Fair Dealing
1
Cross Motions
1
DaimlerChrysler
1
Declaratory Judgment Act
1
Defense Strategies
1
Defined Benefit Plans
1
Derivative Suit
1
Discovery Disputes
1
Discovery Rule
1
DNA
1
Double Patent
1
Draft Guidance
1
Drug Pricing
1
Dukes v Wal-Mart
1
ESRD
1
Exhaustion Doctrine
1
Expert Testimony
1
Extrapolation
1
Extraterritoriality Rules
1
False Claims Act (FCA)
1
FDCA
1
Federal Arbitration Act
1
Federal Rule 12(b)(6)
1
FEHA
1
Filing Fees
1
First Sale Doctrine
1
Fisher v University of Texas
1
Free Trade Agreements
1
Frivolous Lawsuits
1
FTC v Actavis
1
Genetically Engineered Seed
1
Health Canada
1
Health Insurance
1
HHS
1
Hoffman LaRoche
1
Hollingsworth v Perry
1
Hospitals
1
Human Genes
1
Impression Products v Lexmark International
1
Indemnity Insurance
1
Infringement
1
Innovator Liability
1
Insider Trading
1
Intellectual Property Protection
1
Inventions
1
Irreparable Harm
1
IRS
1
iTraxx CDS indices
1
Joint Venture
1
Judgment As A Matter Of Law
1
Kickbacks
1
Kirtsaeng v. John Wiley & Sons
1
Kyle Bass
1
Labeling
1
Legislative Agendas
1
License Agreements
1
Litigation Privilege
1
M&G Polymers v Tackett
1
Mandatory Victim's Restitution Act
1
Manufacturers
1
Marketing
1
Markman Hearing
1
Material Nonpublic Information
1
Materiality
1
Medical Devices
1
Medical Expenses
1
Medicare Access and CHIP Reauthorization (MACRA)
1
Method Claims
1
Misappropriation
1
Misrepresentation
1
Moench Presumption
1
Montanile v Board of Trustees
1
More Harm Than Good Standard
1
Morgan Stanley
1
Motion to Compel
1
Motion to Expedite
1
Motion To Stay
1
Motion To Strike
1
Mount Holly v Mt. Holly Citizens in Action
1
New Legislation
1
Nike
1
NLRB
1
No-Action Letters
1
Noninfringement
1
Notice and Comment
1
Notice of Appeal
1
Notice of Intent
1
Notice Provisions
1
Order To Compel
1
Patent Expiration
1
Patent Portfolios
1
Patent-in-Suit
1
Pay-For-Delay
1
Pensions
1
Personal Jurisdiction
1
Pharmacies
1
Physicians
1
Plan Administrators
1
Plan Participants
1
Pleadings
1
PMNOC Regulations
1
Preponderance of the Evidence
1
Principal Place of Business
1
Prior Art
1
Product Exclusivity
1
Public Use
1
Purple Book
1
Qualified Settlement Funds
1
Qui Tam
1
Reasonable Reliance Claims
1
Relators
1
Remand
1
Renewal Fees
1
Retaliation
1
Reversal
1
Ripeness
1
Rule 10b-5
1
Rule 23(b)(3)
1
Rule 23(f)
1
Rule 26
1
Rulemaking Process
1
Same-Sex Marriage
1
Scheduling Orders
1
Scienter
1
Scope of Discovery Requests
1
Sealed Records
1
Section 220 Request
1
Section 337
1
Section 8
1
Section 8(a)
1
Sham Litigation Exception
1
Shareholder Litigation
1
Sherman Act
1
SLUSA
1
Standing
1
Statutory Interpretation
1
Supervisors
1
Supremacy Clause
1
Supreme Court of Canada
1
TC Heartland LLC v Kraft Foods
1
Trade Secrets
1
Trademark Registration
1
Trials
1
TRICARE
1
TRO
1
UBS
1
UK Patents Act
1
Unclean Hands
1
Uniform Commercial Code (UCC)
1
US v Windsor
1
UT Southwestern Medical v Nassar
1
Utility Patents
1
Vance v. Ball State University
1
Venue
1
Whistleblowers
1
Whole Woman's Health v Hellerstedt
1
Willful Infringement
1
Work Product Privilege
1
Written Notice
1
Yard Man
1
Zika